BioSpace.com

Biotech and Pharmaceutical
News & Jobs
Search the Site
 
   
Biotechnology and Pharmaceutical Channel Medical Device and Diagnostics Channel Clinical Research Channel BioSpace Collaborative    Job Seekers:  Register | Login          Employers:  Register | Login  

NEWSLETTERS
Free Newsletters
Archive
My Subscriptions

NEWS
News by Subject
News by Disease
News by Date
PLoS
Search News
Post Your News
JoVE

CAREER NETWORK
Job Seeker Login
Most Recent Jobs
Browse Biotech Jobs
Search Jobs
Post Resume
Career Fairs
Career Resources
For Employers

HOTBEDS
Regional News
US & Canada
  Biotech Bay
  Biotech Beach
  Genetown
  Pharm Country
  BioCapital
  BioMidwest
  Bio NC
  BioForest
  Southern Pharm
  BioCanada East
  US Device
Europe
Asia

DIVERSITY

INVESTOR
Market Summary
News
IPOs

PROFILES
Company Profiles

START UPS
Companies
Events

INTELLIGENCE
Research Store

INDUSTRY EVENTS
Biotech Events
Post an Event
RESOURCES
Real Estate
Business Opportunities

 News | News By Subject | News by Disease News By Date | Search News
eNewsletter Signup
Miles
Km80.5

   

Nipro Diagnostics, Inc. Purchases New Building, Expands Fort Lauderdale Operations; Creating New Jobs


1/26/2012 7:26:55 AM

FORT LAUDERDALE, Fla.--(BUSINESS WIRE)-- Nipro Diagnostics, Inc., a leading manufacturer and marketer of blood glucose monitoring products and supplies for diabetes management, has purchased a new corporate headquarters facility in Fort Lauderdale to house many of the company’s operations. The building, located at 2200 West Cypress Creek Road in Fort Lauderdale, will serve as global headquarters for the executive team, marketing, finance, operations, accounting, R&D, regulatory, and human resources of Nipro Diagnostics. Manufacturing will continue to take place at the company’s facility at NW 55th Court in Fort Lauderdale, purchased in December 2011.

“This new corporate headquarters complex of almost 80,000 square feet, located on seven acres, affords us the space and capabilities to grow our business and keep up with increasing demand for our products,” said Scott Verner, President and CEO of Nipro Diagnostics. “Just as we’re dedicated to providing high quality and affordable diabetes care products, we’re committed to Fort Lauderdale, expanding our operations here and creating new jobs.” It is anticipated that Nipro Diagnostics’ operations will move to the new building in the second quarter of 2012. This is the third building Nipro Diagnostics has acquired in the last six months.

The announcement of this new facility comes shortly after Nipro Diagnostics was named 2011 Manufacturer of the Year by the Manufacturers Association of Florida in the large-company (500+ employee) category in December 2011. The company’s TRUEresult® and TRUE2go®Blood Glucose Monitors were also recently awarded ratings of “recommended” by a leading consumer magazine, achieving scores superior to those of many higher priced, nationally-brand meters. Nipro Diagnostics manufactures blood glucose monitors that are co-branded under the names of leading pharmacy chains and distributors.

About Nipro Diagnostics, Inc.

Based in Fort Lauderdale, Nipro Diagnostics, Inc. is a leading developer, manufacturer and marketer of diabetes management products. The company offers a portfolio of high quality blood glucose monitoring systems and products available around the world.

Nipro Diagnostics is the exclusive supplier of blood glucose monitoring systems, co-branded under the TRUE name, for leading pharmacies including CVS, Rite Aid, Walgreens and Wegmans; as well as for distributors such as AmerisourceBergen, Cardinal Health, McKesson, Invacare and Liberty Medical. For more information, please visit www.niprodiagnostics.com.

Contact:

Nipro Diagnostics, Inc.

Lisa Nardi, 800-342-7226, ext. 2183

Vice President, Marketing

lnardi@niprodiagnostics.com



Read at BioSpace.com

 
 

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES